About
Basic Data Updated:
8 days agoAarti Drugs Limited, known for its high credit ratings, is responsible for the production of APIs, formulations, advanced intermediates, and specialty chemicals. A wide range of products, including vitamins, anti-arthritis, anti-fungal, antibiotics, ACE inhibitors, anti-diabetic, anti-cholinergic, sedatives, and anti-depressant drugs, are offered by ADL. With 10 manufacturing facilities located in Maharashtra and Gujarat, all certified under good manufacturing practices, ADL has a strong presence in the global market, exporting to over 90 countries. The company is publicly listed on both the Bombay Stock Exchange and National Stock Exchange, and is a subsidiary of the Aarti Group of Industries, with a total worth of USD 500 million. Its manufacturing facilities at Tarapur and Sarigam are ... Read More
Industry
Company Details
- Location
Thane, Maharashtra, India
- Website1222442
- Telephone1222442
- Email Address1222442
| CIN/LLPIN/FCRN | L37060MH1984PLC055433 |
| Company No. | 055433 |
| Stock Symbol | BSE : 524348 NSE : AARTIDRUGS |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 28 Sep 1984 |
| Date of AGM | 26 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Listed |
| ROC Code | Roc Mumbai |
Products or Services related to Aarti Drugs Limited
Anti Infective API
Pharmaceutical Medicine
Antidiabetic Drug
Dairy Chemical Products
Financials of Aarti Drugs Limited
Enhance accessibility to Aarti Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Aarti Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Aarti Drugs Limited
Unlock and access historical data on people associated with Aarti Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (5)
HS
Harshit Savla
Managing DirectorAppointment Date: 02-Jan-1987
Status: Current
PP
Prakash Patil Managing DirectorAppointment Date: 05-Jan-1985
Status: Current
RD
Rushikesh Deole Company SecretaryAppointment Date: 23-Apr-2019
Status: Current
AP
Adhish Patil CFOAppointment Date: 04-Apr-2014
Status: Current
RG
Rashesh Gogri Managing DirectorAppointment Date: 16-Aug-2012
Status: Current
Board Members(9)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Jan 2024 | ₹300.00 Cr | Open |
Axis Bank Limited Creation Date: 26 Mar 2011 | ₹1,194.00 Cr | Open |
Others Creation Date: 20 Sep 2018 | ₹64.00 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aarti Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aarti Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
16 years 12 days 
Recent activity within the organization
Charges
A charge with Others of Rs. 300.00 cr registered on 25 Jan 2024 with Charge ID 100855330 was modified on 26 Mar 2024.
26 Mar 2024Charges
A charge with Others amounted to Rs. 300.00 cr with Charge ID 100855330 was registered on 25 Jan 2024.
25 Jan 2024Annual General Meeting
Aarti Drugs Limited last Annual general meeting of members was held on 26 Sep 2023 as per latest MCA records.
26 Sep 2023Balance Sheet
Aarti Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
31 Mar 2023Director Appointment
Ankit Vikram Paleja was appointed as a Director was appointed as a Director on 13 Oct 2021 & has been associated with this company since 2 years 6 months .
13 Oct 2021
Recent News, Updates & Announcement
Aarti Drugs Q1 Results Net profit surges 39 YoY to 48 crore Mint.The revenue of the company also witnessed a growth of 6 percent from 6222 crore to 6617 crore during on a YearonYear basis.
mint 22 Jul 2023
- Aarti Drugs Q3 Net Dips 10 Pc At Rs 2089 Cr.
Btvi 11 Feb 2019
- Global Nicotinic Acid Vitamin B3 Market Status 2018 Aarti Drugs Brother Enterprises Holding DSM.
Talkdailynews 25 Jul 2018
- Indias Aarti Drugs DecQtr Consol Profit Rises.
Financetime 13 Feb 2018
- Drug duo announce buyback.
The Telegraph 09 Jan 2018
Frequently asked questions
What is the Incorporation or founding date of Aarti Drugs Limited?
